Skip to main content
. 2022 Jul 30;11(15):4453. doi: 10.3390/jcm11154453
AEs adverse events
AE-QoL angioedema quality of life questionnaire
BTK Bruton’s tyrosine kinase
CI confidence interval
CRS chronic rhinosinusitis
CU chronic urticaria
CU-Q2oL chronic urticaria quality of life questionnaire
CSU chronic spontaneous urticaria
FDA Food and Drug Administration
EMA European Medicine Agency
FcεRI high affinity IgE receptor
DLQI dermatology life quality index
H1AH H1 antihistamines
H2AH H2 antihistamines
HRQoL health-related quality of life
HSS7 weekly hives severity score
IgE immunoglobulin E
IgG immunoglobulin G
ISI insomnia severity index
ISS7 weekly itch severity score
LTRAs leukotriene receptor antagonists
mAbs monoclonal antibodies
OR odds ratio
RDBPCT randomized double-blind placebo controlled trial
RCTs randomized controlled trials
SAEs serious adverse events
TPO thyroperoxidase
TSLP anti-thymic stromal lymphopoietin
UAS7 weekly urticaria activity score
Versus vs.
WPAI work productivity and activity impairment